title: [New oral anticoagulants in the prevention of embolic complications in patients with atrial fibrillation. Polish Cardiac Society, Polish Neurological Society and Working Group on Haemostasis of the Polish Society of Haematologists and Transfusiologists consensus statement].
authors.affiliation: Klinika Chorób Wewnętrznych i Kardiologii, Warszawski Uniwersytet Medyczny, Warszawa. piotr.pruszczyk@wum.edu.pl
authors.forename: Piotr
authors.initials: P
authors.lastname: Pruszczyk
authors.forename: Janina
authors.initials: J
authors.lastname: Stępińska
authors.forename: Waldemar
authors.initials: W
authors.lastname: Banasiak
authors.forename: Anna
authors.initials: A
authors.lastname: Członkowska
authors.forename: Grzegorz
authors.initials: G
authors.lastname: Opolski
authors.forename: Maciej
authors.initials: M
authors.lastname: Niewada
authors.forename: Piotr
authors.initials: P
authors.lastname: Ponikowski
authors.forename: Michał
authors.initials: M
authors.lastname: Tendera
authors.forename: Jerzy
authors.initials: J
authors.lastname: Windyga
mesh_terms: D000284:Administration, Oral; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000627:therapeutic use*; D000991:Antithrombins / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications*; D004617:Embolism / Q000209:etiology / Q000517:prevention & control*; D065427:Factor Xa Inhibitors; D005260:Female; D006801:Humans; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000517:prevention & control
chemical_list: D000925:Anticoagulants; D000991:Antithrombins; D065427:Factor Xa Inhibitors